Gia-Phong Vu Selected Research

Ribonuclease P (RNase P)

12/2017	Inhibition of Murine Cytomegalovirus Infection in Animals by RNase P-Associated External Guide Sequences.
1/2017	Inhibition of human cytomegalovirus immediate early gene expression and growth by a novel RNase P ribozyme variant.
1/2013	RNase P-associated external guide sequence effectively reduces the expression of human CC-chemokine receptor 5 and inhibits the infection of human immunodeficiency virus 1.
2/2011	Oral delivery of RNase P ribozymes by Salmonella inhibits viral infection in mice.
4/2010	Salmonella-mediated delivery of RNase P-based ribozymes for inhibition of viral gene expression and replication in human cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gia-Phong Vu Research Topics

Disease

9	Infections 01/2018 - 01/2010
3	Virus Diseases (Viral Diseases) 12/2017 - 04/2010
2	Bacterial Infections (Bacterial Infection) 09/2011 - 01/2010
2	Salmonella Infections (Salmonellosis) 06/2010 - 01/2010
1	HIV Infections (HIV Infection) 01/2012
1	Enterocolitis 01/2010

Drug/Important Bio-Agent (IBA)

5	Ribonuclease P (RNase P)IBA 12/2017 - 04/2010
4	Catalytic RNA (Ribozymes)IBA 01/2017 - 04/2010
2	RNA (Ribonucleic Acid)IBA 01/2013 - 09/2011
2	Proteins (Proteins, Gene)FDA Link 06/2010 - 01/2010
2	N- succinimidyl- 5- iodo- 3- pyridinecarboxylic acidIBA 06/2010 - 01/2010
1	InterferonsIBA 01/2018
1	CCR5 Receptors (CCR5 Receptor)IBA 01/2013
1	pgRNAIBA 01/2013
1	Messenger RNA (mRNA)IBA 01/2013
1	Virulence Factors (Pathogenicity Factors)IBA 09/2011
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 06/2010
1	EpitopesIBA 01/2010
1	lambda Spi-1IBA 01/2010
1	Type III Secretion SystemsIBA 01/2010

Therapy/Procedure

1	Therapeutics 12/2017